Lemaitre Vascular (LMAT) Cash from Investing Activities Growth (3y) (2013 - 2026)
Lemaitre Vascular (LMAT) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -53.20% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 15.82% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -27.34% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 19.58% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -3.15% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -35.55% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 7.86% |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | -64.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.20% |
| Dec 31, 2025 | -247.20% |
| Sep 30, 2025 | -48.04% |
| Jun 30, 2025 | -156.13% |
| Mar 31, 2025 | -100.50% |
| Dec 31, 2024 | -188.44% |
| Sep 30, 2024 | 36.97% |
| Jun 30, 2024 | -98.73% |
| Mar 31, 2024 | -30.60% |
| Dec 31, 2023 | -37.78% |
| Sep 30, 2023 | -110.39% |
| Jun 30, 2023 | 44.98% |
| Mar 31, 2023 | -391.26% |
| Dec 31, 2022 | 51.60% |
| Sep 30, 2022 | -13.88% |
| Jun 30, 2022 | 31.82% |
| Mar 31, 2022 | 64.28% |
| Dec 31, 2021 | -98.02% |
| Sep 30, 2021 | -139.80% |
| Jun 30, 2021 | 29.88% |